Lupin hold majority stake in Generic Health
Lupin has notified the Bombay Stock Exchange (BSE) that is has acquired a majority stake in Australian pharmaceutical company, Generic Health.
Archives for September 29, 2010
Covance & Sanofi ink 10-year, $2.2bn strategic R&D alliance
Covance has inked a 10-year strategic alliance, worth up to $2.2bn, with Sanofi-Aventis and acquired two European sites from the big pharma.
SP Scientific using Praxair tech to control lyophilisation
SP Scientific is combining its lyophilisation equipment with ControLyo from Praxair to enable precise control over the freeze-drying process.
Zydus Nycomed API site to start production in December
Zydus Nycomed expects commercial production at its newly commissioned API plant in Navi Mumbai, India to begin in December 2010.
RXi and EyeGate eye deal on non-invasive ocular RNAi delivery
RXi Pharmaceuticals and EyeGate Pharma will unite to develop non-invasive, needle-free ocular delivery of RNAi therapeutics using the EyeGate II system for the treatment of retinal disorders.
Almirall ‘hit’ it off with Evotec in ion channel agreement
Anglo-German company Evotec is joining forces with Almirall to identify small molecule modulators of an ion channel target involved in respiratory diseases.
Covance adds 40,000 sq ft US biotech services laboratory
Covance has added a 40,000 sq ft biotech laboratory to its site in Indiana, US site to support its relationship with Eli Lilly and boost capacity outside Europe.
Versatile infeed systems cut total cost of ownership and downtime
High production volumes, a reduction in the total cost of ownership, flexibility and a speedy delivery time are benefits claimed by Bosch for its new range of infeed systems launched this week at FachPack in Germany.